On the public citation graph

Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo

0 signed · 64 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s00203-009-0490-yopenalex-snapshot
A potential antimicrobial treatment against ESBL-producing Klebsiella pneumoniae using the tellurium compound AS101
inferredcites →https://doi.org/10.1007/s12223-018-0585-4openalex-snapshot
Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal
inferredcites →https://doi.org/10.1016/j.autrev.2014.08.003openalex-snapshot
The effect of the novel tellurium compound AS101 on autoimmune diseases
inferredcites →https://doi.org/10.1016/j.bbapap.2008.11.005openalex-snapshot
Outer membrane permeability and antibiotic resistance
inferredcites →https://doi.org/10.1016/j.bioorg.2021.104786openalex-snapshot
Mefloquine synergism with anti-tuberculosis drugs and correlation to membrane effects: Biologic, spectroscopic and molecular dynamics simulations studies
inferredcites →https://doi.org/10.1016/j.biotechadv.2018.11.013openalex-snapshot
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
inferredcites →https://doi.org/10.1016/j.ijantimicag.2021.106309openalex-snapshot
Mefloquine enhances the activity of colistin against antibiotic-resistant Enterobacterales in vitro and in an in vivo animal study
inferredcites →https://doi.org/10.1016/j.jaut.2019.02.006openalex-snapshot
AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells
inferredcites →https://doi.org/10.1016/j.jbiotec.2014.09.003openalex-snapshot
Antibiotic resistance in Pseudomonas aeruginosa biofilms: Towards the development of novel anti-biofilm therapies
inferredcites →https://doi.org/10.1016/j.jiph.2023.05.024openalex-snapshot
Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study
inferredcites →https://doi.org/10.1016/j.jneuroim.2014.05.015openalex-snapshot
The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis
inferredcites →https://doi.org/10.1016/j.jsps.2019.11.021openalex-snapshot
Association of OprF mutant and disturbance of biofilm and pyocyanin virulence in pseudomonas aeruginosa
inferredcites →https://doi.org/10.1016/j.mib.2013.06.013openalex-snapshot
Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies
inferredcites →https://doi.org/10.1016/j.virusres.2012.03.004openalex-snapshot
In vitro and in vivo activity of AS101 against West Nile virus (WNV)
inferredcites →https://doi.org/10.1016/s1473-3099(17)30753-3openalex-snapshot
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
inferredcites →https://doi.org/10.1016/s1473-3099(20)30477-1openalex-snapshot
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals
inferredcites →https://doi.org/10.1017/ice.2016.174openalex-snapshot
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
inferredcites →https://doi.org/10.1038/330173a0openalex-snapshot
A new immunomodulating compound (AS-101) with potential therapeutic application
inferredcites →https://doi.org/10.1038/nmicrobiol.2017.31openalex-snapshot
Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis
inferredcites →https://doi.org/10.1038/nrd4675openalex-snapshot
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
inferredcites →https://doi.org/10.1038/s41579-022-00682-4openalex-snapshot
Tolerance and resistance of microbial biofilms
inferredcites →https://doi.org/10.1073/pnas.1401876111openalex-snapshot
Antibiotics induce redox-related physiological alterations as part of their lethality
inferredcites →https://doi.org/10.1086/591861openalex-snapshot
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
inferredcites →https://doi.org/10.1089/aid.1992.8.613openalex-snapshot
Inhibition of the Reverse Transcriptase Activity and Replication of Human Immunodeficiency Virus Type 1 by AS 101 In Vitro
inferredcites →https://doi.org/10.1093/femsre/fux010openalex-snapshot
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
inferredcites →https://doi.org/10.1093/jac/dkaa268openalex-snapshot
Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials
inferredcites →https://doi.org/10.1093/jac/dkq353openalex-snapshot
Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
inferredcites →https://doi.org/10.1093/jac/dkr296openalex-snapshot
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
inferredcites →https://doi.org/10.1093/jac/dks185openalex-snapshot
Bactericidal activity of the organo-tellurium compound AS101 against Enterobacter cloacae
inferredcites →https://doi.org/10.1093/jac/dkz285openalex-snapshot
Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study
inferredcites →https://doi.org/10.1111/j.1751-7915.2009.00098.xopenalex-snapshot
Nitric oxide‐mediated dispersal in single‐ and multi‐species biofilms of clinically and industrially relevant microorganisms
inferredcites →https://doi.org/10.1128/aac.00582-11openalex-snapshot
In VitroandIn VivoActivities of Novel, Semisynthetic Thiopeptide Inhibitors of Bacterial Elongation Factor Tu
inferredcites →https://doi.org/10.1128/aac.44.4.848-852.2000openalex-snapshot
Antimicrobial Activities of Mefloquine and a Series of Related Compounds
inferredcites →https://doi.org/10.1128/aac.46.6.1680-1687.2002openalex-snapshot
Mefloquine and New Related Compounds Target the F0Complex of the F0F1H+-ATPase ofStreptococcus pneumoniae
inferredcites →https://doi.org/10.1128/aac.46.8.2679-2683.2002openalex-snapshot
Transmission Electron Microscopic Study of Antibiotic Action on Klebsiella pneumoniae Biofilm
inferredcites →https://doi.org/10.1128/aac.47.3.905-909.2003openalex-snapshot
Synergistic Activity of Colistin and Ceftazidime against Multiantibiotic-Resistant Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
inferredcites →https://doi.org/10.1128/aem.02660-15openalex-snapshot
Mechanisms of Inactivation by High-Voltage Atmospheric Cold Plasma Differ for Escherichia coli and Staphylococcus aureus
inferredcites →https://doi.org/10.1128/cmr.00031-19openalex-snapshot
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
inferredcites →https://doi.org/10.1128/jcm.01106-10openalex-snapshot
In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
inferredcites →https://doi.org/10.1128/mbio.03239-19openalex-snapshot
Rapid Freezing Enables Aminoglycosides To Eradicate Bacterial Persisters via Enhancing Mechanosensitive Channel MscL-Mediated Antibiotic Uptake
inferredcites →https://doi.org/10.1128/spectrum.01231-21openalex-snapshot
Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria in Vitro and in Vivo
inferredcites →https://doi.org/10.1186/1475-2875-9-303openalex-snapshot
Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin
inferredcites →https://doi.org/10.1186/s12941-020-00389-5openalex-snapshot
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
inferredcites →https://doi.org/10.1186/s13104-020-05224-wopenalex-snapshot
Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran
inferredcites →https://doi.org/10.1186/s13756-018-0435-9openalex-snapshot
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
inferredcites →https://doi.org/10.12968/jowc.2014.23.3.93openalex-snapshot
Inhibition of biofilms of Pseudomonas aeruginosa by Medihoney in vitro
inferredcites →https://doi.org/10.1371/journal.pone.0124595openalex-snapshot
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
inferredcites →https://doi.org/10.3109/1040841x.2014.940494openalex-snapshot
Carbapenem resistance inPseudomonas aeruginosaandAcinetobacter baumanniiin the nosocomial setting in Latin America
inferredcites →https://doi.org/10.3389/fcimb.2018.00316openalex-snapshot
Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens
inferredcites →https://doi.org/10.3389/fmicb.2021.790220openalex-snapshot
Combined With Mefloquine, Resurrect Colistin Active in Colistin-Resistant Pseudomonas aeruginosa in vitro and in vivo
inferredcites →https://doi.org/10.3390/pathogens10121552openalex-snapshot
Synergistic Combination of AS101 and Azidothymidine against Clinical Isolates of Carbapenem-Resistant Klebsiella pneumoniae
inferredcites →https://doi.org/10.3390/ph14080795openalex-snapshot
Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae
inferredcites →https://doi.org/10.3390/ph14080823openalex-snapshot
In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii
inferredcites →https://doi.org/10.3390/pharmaceutics14010031openalex-snapshot
Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients
inferredcites →https://doi.org/10.3390/pharmaceutics14061266openalex-snapshot
Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
inferredcites →https://doi.org/10.4049/jimmunol.169.1.384openalex-snapshot
Anti-IL-10 Therapeutic Strategy Using the Immunomodulator AS101 in Protecting Mice from Sepsis-Induced Death: Dependence on Timing of Immunomodulating Intervention

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4854716openalex-extracted
Ovicidal Activity of Blending Diaryl Dichalcogenides and Ivermectin Against Fasciola Hepatica: An Alternative for Repurposing the Macrocyclic Lactones Group
inferred← citeshttps://doi.org/10.1016/j.actatropica.2024.107363openalex-snapshot
Ovicidal activity of diaryl dichalcogenides and ivermectin on Fasciola hepatica: A novel candidate for a blending-based therapeutic strategy
inferred← citeshttps://doi.org/10.1016/j.vetpar.2025.110529openalex-snapshot
A blending-based therapeutic strategy using diaryl dichalcogenides and ivermectin against gastrointestinal nematodes of small ruminants
inferred← citeshttps://doi.org/10.1128/mbio.04016-24openalex-snapshot
Mefloquine reduces the bacterial membrane fluidity of Acinetobacter baumannii and distorts the bacterial membrane when combined with polymyxin B
inferred← citeshttps://doi.org/10.1155/cjid/1388332openalex-snapshot
Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1590/s1984-29612026017openalex-snapshot
Efficacy of selenium- and tellurium-based organocompounds against ruminant gastrointestinal nematodes in vitro
inferred← citeshttps://doi.org/10.3389/fcimb.2024.1470891openalex-snapshot
Progress in the study of mefloquine as an antibiotic adjuvant for combination bacterial inhibition treatment
inferred← citeshttps://doi.org/10.3389/fmicb.2025.1669585openalex-snapshot
A bibliometric analysis and systematic review of drug repurposing against drug-resistant ESKAPE pathogens: a particular focus on Pseudomonas aeruginosa
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.